Welcome to our dedicated page for Reliq Helth Tech news (Ticker: RQHTF), a resource for investors and traders seeking the latest updates and insights on Reliq Helth Tech stock.
Reliq Helth Tech (RQHTF) delivers innovative digital health solutions through telemedicine platforms, wearable devices, and AI-driven analytics. This news hub provides investors and industry observers with essential updates about the company's advancements in healthcare technology.
Access real-time announcements including earnings reports, product launches, strategic partnerships, and regulatory developments. Our curated collection ensures you stay informed about RQHTF's role in shaping remote patient monitoring and data-driven care solutions.
Discover updates across key operational areas: telemedicine platform enhancements, new wearable device certifications, healthcare analytics partnerships, and SaaS model expansions. Each update is verified for accuracy to support informed decision-making.
Bookmark this page for streamlined access to Reliq Helth Tech's latest developments in healthtech innovation. Check regularly for authoritative updates that matter to stakeholders in the digital healthcare sector.
Argent BioPharma (ASX:RGT) (OTCQB:RGTLF) has successfully completed a US$4.5 million capital raise through a placement of 5,625,000 Units at US$0.80 each. Each Unit includes two ordinary shares and one warrant exercisable at US$0.55 with a three-year expiry.
The placement will be executed in two tranches: Tranche 1 with 5,000,000 shares and 2,500,000 warrants issued immediately, and Tranche 2 with 6,250,000 shares and 3,125,000 warrants subject to shareholder approval. The shares are priced at US$0.40, representing a 370% premium to the 15-day VWAP.
The funds will support Argent's drug development pipeline, particularly CannEpil® clinical studies. The company is conducting a strategic review following LSE delisting and preparing for US National Listing. Sputnik Enterprises , acting as corporate advisor, will receive a 5% cash fee and 1,125,000 warrants.
Reliq Health Technologies has expanded its contract with a large US healthcare group, potentially adding over 30,000 new patients to its iUGO Care platform by the end of 2025. The client, originally using Reliq's services in Florida, will now include facilities in Pennsylvania. This expansion is expected to generate an average revenue of $65 per patient per month. The healthcare group manages over 80,000 patients across Florida, Pennsylvania, Illinois, and Michigan. Reliq's iUGO Care platform offers solutions for remote patient monitoring, chronic care management, and behavioral health integration, which aim to improve health outcomes and reduce care costs.
FAQ
What is the current stock price of Reliq Helth Tech (RQHTF)?
What is the market cap of Reliq Helth Tech (RQHTF)?
